Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
Better Weight Loss Stock: Amgen or Viking Therapeutics?
11:05am, Thursday, 22'nd May 2025
Investors looking to cash in on the fast-growing market for weight management medicines will naturally turn to the two leaders in this area, Eli Lilly and Novo Nordisk. However, several other companie
Amgen Inc. (AMGN) RBC Capital Markets Global Healthcare Conference (Transcript)
11:32am, Wednesday, 21'st May 2025
Amgen Inc. (NASDAQ:AMGN ) RBC Capital Markets Global Healthcare Conference May 21, 2025 9:00 AM ET Company Participants Justin Claeys - VP, IR Kave Niksefat - Senior Vice President of Global Marketing
AMGN Down 10% in 3 Months: How to Play the Stock as Tariff Woes Linger
09:50am, Wednesday, 21'st May 2025
AMGN's consistent top-line growth, an interesting pipeline and rising estimates are good enough reasons to stay invested in the stock for now.
Amgen vs Bristol Myers: Which Biotech Giant Has Better Prospects?
02:31pm, Monday, 19'th May 2025
At current levels, we believe AMGN scores above BMY, buoyed by solid fundamentals and recent positive estimate revisions.
AMGEN TO PRESENT AT THE 2025 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
04:01pm, Friday, 16'th May 2025
THOUSAND OAKS, Calif. , May 16, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2025 RBC Capital Markets Global Healthcare Conference at 9:00 a.m.
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
10:01am, Friday, 16'th May 2025
Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.
Amgen owes $406 million for monopolizing cholesterol drug market, US jury says
04:57pm, Thursday, 15'th May 2025
A federal jury in Delaware said on Thursday that biotech company Amgen owes competitor Regeneron more than $406 million for engaging in anticompetitive behavior to increase sales of its cholesterol-re
Stock Of The Day: Amgen Slips With Healthcare Sector, But Signals Point To A Reversal
03:25pm, Thursday, 15'th May 2025
The stock of Amgen Inc. AMGN is trading higher on Thursday. But along with the rest of the healthcare sector, it is still in a steep downtrend.
Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments
02:02pm, Thursday, 15'th May 2025
Federal court jury found Amgen liable for violating antitrust and tort laws by using cross-therapeutic bundled rebates to prevent Praluent ® (alirocumab) from competing in the market
Amgen Inc. (AMGN) BofA Securities 2025 Healthcare Conference (Transcript)
04:21pm, Wednesday, 14'th May 2025
Amgen Inc. (NASDAQ:AMGN ) BofA Securities 2025 Healthcare Conference Call May 14, 2025 12:20 PM ET Company Participants Peter Griffith - Executive Vice President and Chief Financial Officer Justin Cla
Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared
08:40am, Tuesday, 13'th May 2025
President Trump issues an executive order that will push drugmakers to offer prescription drugs to U.S. cash-pay consumers at lower prices.
Dr. Scott Gottlieb: What to expect from President Trump's executive order to lower drug prices
12:36pm, Monday, 12'th May 2025
Scott Gottlieb, former FDA commissioner, joins CNBC's 'Squawk on the Street' to discuss how the White House may plan to cut drug prices.
Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet
12:30pm, Monday, 12'th May 2025
President Trump has announced today he plans to reduce U.S. drug prices by 30-80% via an Executive Order, targeting Big Pharma's high costs and profits. U.S. drug prices are significantly higher (up t
Pharma Stocks Hit by Trump's Vow to Cut US Prescription Drug Costs
10:41am, Monday, 12'th May 2025
The price cuts would see that U.S. consumers pay the same amount as the nation that pays the lowest price for that drug.
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
04:01pm, Friday, 09'th May 2025
THOUSAND OAKS, Calif. , May 9, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 9:20 a.m.
